Invention Grant
- Patent Title: 5-HT7 receptor antagonists
- Patent Title (中): 5-HT7受体拮抗剂
-
Application No.: US11658924Application Date: 2005-08-18
-
Publication No.: US08188115B2Publication Date: 2012-05-29
- Inventor: Antoni Torrens Jover , Josep Mas Prio , Susana Yenes Minguez , Mónica Garcia Lopez , Alberto Dordal Zueras , Luz Romero Alonso , Helmut Henrich Buschmann
- Applicant: Antoni Torrens Jover , Josep Mas Prio , Susana Yenes Minguez , Mónica Garcia Lopez , Alberto Dordal Zueras , Luz Romero Alonso , Helmut Henrich Buschmann
- Applicant Address: ES Barcelona
- Assignee: Laboratorios Del Dr. Esteve, S.A.
- Current Assignee: Laboratorios Del Dr. Esteve, S.A.
- Current Assignee Address: ES Barcelona
- Agency: Locke Lord LLP
- Priority: EP04380171 20040818; ES200402049 20040818
- International Application: PCT/EP2005/008978 WO 20050818
- International Announcement: WO2006/018308 WO 20060223
- Main IPC: C07D217/18
- IPC: C07D217/18 ; A61K31/47
Abstract:
The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some tetrahydroisoquinoline substituted sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.
Public/Granted literature
- US20090163542A1 5-ht7 receptor antagonists Public/Granted day:2009-06-25
Information query
